| 000 | 01473 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511125653.0 | ||
| 264 | 0 | _c19770729 | |
| 008 | 197707s 0 0 eng d | ||
| 022 | _a0362-1642 | ||
| 024 | 7 |
_a10.1146/annurev.pa.17.040177.001143 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHaskell, C M | |
| 245 | 0 | 0 |
_aImmunologic aspects of cancer chemotherapy. _h[electronic resource] |
| 260 |
_bAnnual review of pharmacology and toxicology _c1977 |
||
| 300 |
_a179-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBCG Vaccine |
| 650 | 0 | 4 |
_aCyclophosphamide _xpharmacology |
| 650 | 0 | 4 |
_aCytarabine _xpharmacology |
| 650 | 0 | 4 |
_aDaunorubicin _xpharmacology |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFluorouracil _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunosuppression Therapy |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aLevamisole _xpharmacology |
| 650 | 0 | 4 |
_aMercaptopurine _xpharmacology |
| 650 | 0 | 4 |
_aMethotrexate _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPropionibacterium acnes |
| 650 | 0 | 4 |
_aVinca Alkaloids _xpharmacology |
| 773 | 0 |
_tAnnual review of pharmacology and toxicology _gvol. 17 _gp. 179-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1146/annurev.pa.17.040177.001143 _zAvailable from publisher's website |
| 999 |
_c351147 _d351147 |
||